TP53 and neoplasm: Here we show that stratification of patients carrying mutations, CNVs, and co-occurring mutations and CNVs may identify patient subsets showing different prognoses due to mechanisms that may be associated with the aggressiveness of the tumor, e.g., two-hits affecting TP53 or amplification of the mutant PIK3CA alleles, that may be worthy of consideration in clinical stratification.